Navigation Links
Boehringer Ingelheim's Jeff Huth Elected as National Pharmaceutical Council's Chairman of the Board
Date:11/8/2013

WASHINGTON, Nov. 8, 2013 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Jeff Huth, Senior Vice President, Managed Markets, Boehringer Ingelheim Pharmaceuticals Inc. (BI), has been elected chairman of its Board of Directors for 2013-14. Mr. Huth has served on NPC's Board since 2009 and has previously held the positions of vice chair and treasurer.

(Photo:  http://photos.prnewswire.com/prnh/20131108/DC13524)

"Throughout his tenure on our board, Jeff has been dedicated to promoting NPC and its role as a leading health care policy research organization," said NPC President Dan Leonard. "We're looking forward to having Jeff play an even more active role in leading NPC's efforts on issues related to balancing the needs of patients with the population, the value of pharmaceuticals, and the use of real-world evidence."

Mr. Huth has more than 30 years of experience in the pharmaceutical industry, where he has served in a wide spectrum of roles ranging from pre-clinical development to marketing and sales management.  His career with Boehringer Ingelheim has included international assignments at BI's affiliate in the United Kingdom and at corporate headquarters in Germany. Upon returning to the U.S., he assumed responsibility for marketing and in 2009 moved to his current position, for which he is responsible for pricing and contracting, trade relations, health economics and leading field-based teams interacting with customers in the private and government payer channels. In the U.S., BI develops and markets therapies in the respiratory, cardiovascular, metabolic, anti-viral and oncology areas.

The NPC Board also elected Anne Whitaker, President, North America Pharmaceuticals, Sanofi, as Vice Chair; David Martin, Vice President, Managed Markets, Value & Access Group, Eisai Inc. as Treasurer; and Giovanni Caforio, MD, President, U.S. Pharmaceuticals, Bristol-Myers Squibb Company, and Steven Romano, MD, Senior Vice President, Head, Medicines Development Group, Pfizer Inc, to serve on the executive committee.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow. 


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Boehringer Ingelheims interferon-free hepatitis C treatment portfolio strengthened by promising interim Phase 2a data
2. Pivotal Phase 3 Data from Boehringer Ingelheim Hepatitis C Portfolio to be Presented at 64th Annual AASLD Meeting
3. Boehringer Ingelheim Pharmaceuticals, Inc. colabora con Univision Communications Inc. para lanzar una campaña integrada en español
4. Boehringer Ingelheim Pharmaceuticals, Inc. Collaborates With Univision Communications Inc. To Launch An Integrated Campaign In Spanish
5. Boehringer Ingelheims investigational volasertib receives FDA Breakthrough Therapy designation
6. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
7. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
8. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
9. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
10. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
11. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... and Markets has announced the addition of the "Contraceptives - Global ... ... US, Canada , Japan , ... America , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:2/17/2017)... According to a new market research report ... Application (Cleanroom Monitoring, Contamination Monitoring of Liquids), and End User (Healthcare ... the market is expected to reach USD 330.6 Million by 2021 ... from 2016 to 2021. Continue Reading ... ...
(Date:2/17/2017)... Research and Markets has announced the addition of ... to their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
Breaking Medicine Technology:
(Date:2/18/2017)... PA (PRWEB) , ... February 17, 2017 , ... Butler ... about the Stannah Stairlift and other Butler products. Ken was impressed with the ... and agreed to endorse the product on his show. This endorsement by Ken ...
(Date:2/18/2017)... ... February 18, 2017 , ... A ... information and contact points to easily connect elderly veterans of America's armed forces ... elder-care funding. It also conveys material on this year's increase in the Veterans ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells ... the electronic prescribing of controlled and non-controlled substances plus the ability to manage ... in the United States now accept electronic prescriptions, according to the Office of ...
(Date:2/17/2017)... ... February 17, 2017 , ... Corrective Action & Preventive ... FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... and preventive action (PA)? , The methods share techniques and tools but they ...
(Date:2/17/2017)... ... February 17, 2017 , ... MAP Revenue ... that Karen Pilley has been promoted to Chief Executive Officer. , The ... paradigm – a shift that demands the transition from pay-for-service to pay-for-performance models. ...
Breaking Medicine News(10 mins):